210 related articles for article (PubMed ID: 26458935)
21. A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours.
Russell MR; Graham C; D'Amato A; Gentry-Maharaj A; Ryan A; Kalsi JK; Ainley C; Whetton AD; Menon U; Jacobs I; Graham RLJ
Br J Cancer; 2017 Aug; 117(5):666-674. PubMed ID: 28664912
[TBL] [Abstract][Full Text] [Related]
22. Better Predictive Value of Cancer Antigen125 (CA125) as Biomarker in Ovary and Breast Tumors and its Correlation with the Histopathological Type/Grade of the Disease.
Nazmeen A; Maiti S; Mandal K; Roy SK; Ghosh TK; Sinha NK; Mandal K
Med Chem; 2017; 13(8):796-804. PubMed ID: 28440189
[TBL] [Abstract][Full Text] [Related]
23. A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass.
Karlsen MA; Høgdall EV; Christensen IJ; Borgfeldt C; Kalapotharakos G; Zdrazilova-Dubska L; Chovanec J; Lok CA; Stiekema A; Mutz-Dehbalaie I; Rosenthal AN; Moore EK; Schodin BA; Sumpaico WW; Sundfeldt K; Kristjansdottir B; Zapardiel I; Høgdall CK
Gynecol Oncol; 2015 Sep; 138(3):640-6. PubMed ID: 26086566
[TBL] [Abstract][Full Text] [Related]
24. Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: a systematic review.
Ferraro S; Braga F; Lanzoni M; Boracchi P; Biganzoli EM; Panteghini M
J Clin Pathol; 2013 Apr; 66(4):273-81. PubMed ID: 23426716
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Accuracy of Serum Kallikrein-Related Peptidases for Ovarian Cancer: A Systematic Review and Meta-Analysis.
Lan Z; Wang F; Yu X; Zeng X; Xi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1366-74. PubMed ID: 27465901
[TBL] [Abstract][Full Text] [Related]
26. Combination of CA125 and RECAF biomarkers for early detection of ovarian cancer.
Tcherkassova J; Abramovich C; Moro R; Chen C; Schmit R; Gerber A; Moro R
Tumour Biol; 2011 Aug; 32(4):831-8. PubMed ID: 21625941
[TBL] [Abstract][Full Text] [Related]
27. A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
Kaijser J; Van Gorp T; Van Hoorde K; Van Holsbeke C; Sayasneh A; Vergote I; Bourne T; Timmerman D; Van Calster B
Gynecol Oncol; 2013 May; 129(2):377-83. PubMed ID: 23360924
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
Gschwantler-Kaulich D; Weingartshofer S; Rappaport-Fürhauser C; Zeillinger R; Pils D; Muhr D; Braicu EI; Kastner MT; Tan YY; Semmler L; Sehouli J; Singer CF
PLoS One; 2017; 12(12):e0189641. PubMed ID: 29244844
[TBL] [Abstract][Full Text] [Related]
29. Alternatives to risk-reducing surgery for ovarian cancer.
Gadducci A; Sergiampietri C; Tana R
Ann Oncol; 2013 Nov; 24 Suppl 8():viii47-viii53. PubMed ID: 24131970
[TBL] [Abstract][Full Text] [Related]
30. Human epididymis protein 4 for differential diagnosis between benign gynecologic disease and ovarian cancer: a systematic review and meta-analysis.
Lin J; Qin J; Sangvatanakul V
Eur J Obstet Gynecol Reprod Biol; 2013 Mar; 167(1):81-5. PubMed ID: 23228410
[TBL] [Abstract][Full Text] [Related]
31. A meta-analysis of serum cancer antigen 125 array for diagnosis of ovarian cancer in Chinese.
Liao XY; Huang GJ; Gao C; Wang GH
J Cancer Res Ther; 2014 Nov; 10 Suppl():C222-4. PubMed ID: 25450287
[TBL] [Abstract][Full Text] [Related]
32. Simple laboratory score improves the preoperative diagnosis of adnexal mass.
Watrowski R; Zeillinger R
Tumour Biol; 2016 Apr; 37(4):4343-9. PubMed ID: 26499778
[TBL] [Abstract][Full Text] [Related]
33. Serum B7 homologous body 4 for the diagnosis of ovarian cancer in Chinese Han women: A meta-analysis.
Lan Z; Fu D; Xi M
J Cancer Res Ther; 2018 Jun; 14(Supplement):S433-S436. PubMed ID: 29970702
[TBL] [Abstract][Full Text] [Related]
34. Serum CA125 in combination with ferritin improves diagnostic accuracy for epithelial ovarian cancer.
Zhao J; Guo N; Zhang L; Wang L
Br J Biomed Sci; 2018 Apr; 75(2):66-70. PubMed ID: 29452533
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Serum Human Epididymis Protein 4 and Carbohydrate Antigen 125 as Markers in Endometrial Cancer: A Meta-Analysis.
Hu L; Du S; Guo W; Chen D; Li Y
Int J Gynecol Cancer; 2016 Feb; 26(2):331-40. PubMed ID: 26807564
[TBL] [Abstract][Full Text] [Related]
36. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer.
Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of peripheral blood Kisspeptin mRNA and plasma CA125 protein for detection of epithelial ovarian cancer in patients who have ever been pregnant.
Chen L; Liu M; Ji J; Lin W; Shan F; Liu H
Neoplasma; 2016; 63(6):999-1006. PubMed ID: 27596301
[TBL] [Abstract][Full Text] [Related]
38. Serum Human Epididymis Protein 4 Combined with Carbohydrate Antigen 125 for Endometrial Carcinoma Diagnosis: A Meta-Analysis and Systematic Review.
Huang GQ; Xi YY; Zhang CJ; Jiang X
Genet Test Mol Biomarkers; 2019 Aug; 23(8):580-588. PubMed ID: 31373853
[No Abstract] [Full Text] [Related]
39. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY
Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246
[TBL] [Abstract][Full Text] [Related]
40. Clinical value of a new serum tumor marker, CA125II, in gynecologic disease: comparison with CA125.
Tamakoshi K; Kikkawa F; Hasegawa N; Ishikawa H; Mizuno K; Kawai M; Tomoda Y
Gynecol Obstet Invest; 1995; 39(2):125-9. PubMed ID: 7737582
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]